New stable solvate crystalline forms of eluxadoline
CN105121453A
Stable solid forms of Regadenoson
EP2927235A1
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
EP2913332A1
Crystalline form of tiotropium bromide with lactose
EP2824187A1
Biocatalyzed synthesis of the optically pure (R) and (S) 3-methyl-1,2,3,4-tetrahydroquinoline and their use as chiral synthons for the preparation of the antithrombotic (21R)- and (21S)-argatroban
EP2801577A1
Process for the preparation of aminoaryl- and aminoheteroaryl boronic acids and esters
AU2011273044A1
New process for the synthesis of tapentadol and intermediates thereof
EP2402350A1
New water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins.
EP2528892A1
Process for the synthesis of lacosamide
CA2780842A1
New process for the preparation of tapentadol and intermediates thereof
CA2763034A1
A chemo-enzymatic approach to the synthesis of pimecrolimus
AT505606A4
Preparing 2-fluoroadenine, comprises converting 2,6-diaminopurine in the presence of nitrite, heating the mixture, mixing and quenching the heated mixture, separating, preferably filtering the mixture, washing the solid materials
US2010035796A1
17-alpha-substituted derivatives of estradiol with wound-healing activity
EP1586579A1
Process for the preparation of delta(15-16)-17-ketosteroids and use thereof in the synthesis of pharmacologically active compounds
